Cutler Group LP Immunic, Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$3.0 - $5.49 $600 - $1,098	-200 Reduced 7.41%	2,500 $0
Q2 2022 Aug 04, 2022	BUY	$3.13 - $12.25 $5,947 - $23,275	1,900 Added 237.5%	2,700 $0
Q1 2022 Apr 14, 2022	BUY	$9.54 - $14.26 $5,723 - $8,556	600 Added 300.0%	800 $0
Q3 2021 Oct 26, 2021	BUY	$8.05 - $13.29 $805 - $1,329	100 Added 100.0%	200 $0
Q4 2020 Jan 21, 2021	SELL	$14.8 - $20.37 $79,920 - $109,998	-5,400 Reduced 98.18%	100 $0
Q3 2020 Oct 27, 2020	BUY	$11.74 - $22.0 $64,570 - $121,000	5,500 New	5,500 $4,000

56.3M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $30.3M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.